CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-14 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −2,448 | $77.36 | $189K | 170,083 |
| 2026-02-14 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Shares withheld for taxes | −485 | $77.36 | $38K | 38,109 |
| 2026-02-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $76.80 | $38K | 69,329 |
| 2026-02-12 | Davis Krista SVP, CHIEF HR OFFICER | Shares withheld for taxes | −1,180 | $76.70 | $91K | 54,367 |
| 2026-02-12 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes 10b5-1 | −1,534 | $76.70 | $118K | 69,829 |
| 2026-02-12 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −1,608 | $76.70 | $123K | 67,738 |
| 2026-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes 10b5-1 | −3,173 | $76.70 | $243K | 99,598 |
| 2026-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Sale 10b5-1 | −7,032 | $76.55 | $538K | 92,566 |
| 2026-02-12 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,775 | $76.70 | $136K | 77,982 |
| 2026-02-12 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −11,688 | $76.70 | $896K | 368,872 |
| 2026-02-12 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −2,829 | $76.70 | $217K | 172,531 |
| 2026-02-12 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Shares withheld for taxes | −566 | $76.70 | $43K | 38,594 |
| 2026-02-11 | Davis Krista SVP, CHIEF HR OFFICER | Shares withheld for taxes | −3,017 | $76.25 | $230K | 55,547 |
| 2026-02-11 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes | −3,011 | $76.25 | $230K | 71,363 |
| 2026-02-11 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −4,269 | $76.25 | $326K | 69,346 |
| 2026-02-11 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Shares withheld for taxes | −2,898 | $76.25 | $221K | 89,940 |
| 2026-02-11 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −4,546 | $76.25 | $347K | 102,771 |
| 2026-02-11 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −4,267 | $76.25 | $325K | 79,757 |
| 2026-02-11 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −30,659 | $76.25 | $2.3M | 380,560 |
| 2026-02-11 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −5,503 | $76.25 | $420K | 175,360 |
Page 5 of 15 · 282 trades